1. Home
  2. LIXT vs RECT Comparison

LIXT vs RECT Comparison

Compare LIXT & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.94

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.72

Market Cap

26.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
RECT
Founded
2005
1997
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
26.1M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
LIXT
RECT
Price
$3.94
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.4K
14.6K
Earning Date
11-12-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
N/A
$32,594,177.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.85
Revenue Growth
N/A
5.91
52 Week Low
$0.64
$1.50
52 Week High
$6.26
$7.30

Technical Indicators

Market Signals
Indicator
LIXT
RECT
Relative Strength Index (RSI) 46.50 39.11
Support Level $3.50 $1.59
Resistance Level $4.14 $1.97
Average True Range (ATR) 0.29 0.15
MACD -0.02 0.03
Stochastic Oscillator 48.81 40.45

Price Performance

Historical Comparison
LIXT
RECT

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

Share on Social Networks: